The International Thyroid Cancer Study Group Inc
- Assets
- $4.1m
- Revenue
- $379.5k
- Investments
- $0.0
- Employees
- 0
- Location
- Yorkville, NY
- Founding
- 07/2007
- Data as of
- 12/2023
- EIN
- 20-4773370
Organization Overview
The International Thyroid Cancer Study Group Inc, operating under the name React Foundation, is located in Yorkville, NY. The organization was established in 2007. According to its NTEE Classification (H50) the organization is classified as: Nerve, Muscle & Bone Diseases Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. React Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, React Foundation generated $379.5k in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 0.5% each year. All expenses for the organization totaled $211.2k during the year ending 12/2023. While expenses have increased by 1.3% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE INTERNATIONAL THYROID ONCOLOGY GROUP HAS BEEN ORGANIZED AND WILL BE OPERATED EXCLUSIVELY TO SERVE THE EXEMPT PURPOSE OF (1) FURTHERING SCIENTIFIC RESEARCH INTO POSSIBLE CURES FOR THYROID CANCER; AND (2) EDUCATING THE PUBLIC REGARDING THYROID CANCER AND RESEARCH INTO POSSIBLE CURES FOR THE DISEASE BY HOSTING CONFERENCES, MEETINGS, AND OTHER EDUCATIONAL PROGRAMS, AND BY DISSEMINATING RESEARCH RESULTS REGARDING THYROID CANCER TREATMENTS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
FURTHER THE STUDY AND DISSEMINATION OF KNOWLEDGE OF THYROID CANCER, DEVELOP, INITIATE AND PERFORM MULTI-CENTER, PROSPECTIVE CLINICAL TRIALS FOR ALL TYPES OF TREATMENTS OF THYROID CANCER, CONDUCT INNOVATIVE TRANSLATIONAL RESEARCH STUDIES BASED ON ITOG CLINICAL TRIALS, AND ENCOURAGE CRITICAL INQUIRY AND OPEN PUBLICATION OF RESEARCH RESULTS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Dwight Vicks III MBA Cfo/ Co-Founder | OfficerTrustee | 5 | $0 |
Laura Fugazzola Director | Trustee | 2 | $0 |
Carmello Nucera Director | Trustee | 5 | $0 |
Naifa Busaidy MD Director | Trustee | 2 | $0 |
Julie Ann Sosa MD Finance Chair | Trustee | 2 | $0 |
Andrew Gianoukakis MD Member Chair | Trustee | 5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $229,272 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $229,272 |
| Total Program Service Revenue | $0 |
| Investment income | $150,234 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $379,506 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $49,175 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $1,551 |
| Fees for services: Other | $10,965 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $2,547 |
| All other expenses | $0 |
| Total functional expenses | $211,213 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $76,260 |
| Savings and temporary cash investments | $1,291,650 |
| Pledges and grants receivable | $35,000 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $2,684,712 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $4,087,622 |
| Accounts payable and accrued expenses | $5,000 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $5,000 |
| Net assets without donor restrictions | $4,082,622 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $4,087,622 |
Grants Awarded
Over the last fiscal year, The International Thyroid Cancer Study Group Inc has awarded $40,000 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
OHIO STATE COLLEGE OF MEDICINE PURPOSE: TO ASSIST WTIH ADMINSTRATIVE COSTS | $15,000 |
MASS EYE & EAR PURPOSE: TO ASSIST WITH ADMINISTRATIVE COSTS | $25,000 |